The purpose of this study is to develop an artificial intelligence(AI) assisted scoring system, which can evaluate the disease severity and mucosal healing stage in patients with ulcerative colitis. Then testify whether this new scoring system can help physicians to enhance the accuracy of disease severity assessments in a multi-center clinical practice.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The scoring accuracy of Mayo ES in AI-associated group and conventional group.
Timeframe: 6 months
The scoring accuracy of UCEIS in AI-associated group and conventional group.
Timeframe: 6 months